Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Current Leases (2022 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Current Leases for 4 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 6.92% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 6.92% year-over-year, with the annual reading at $1.3 million for FY2025, 6.92% up from the prior year.
  • Current Leases hit $1.3 million in Q4 2025 for Rapid Micro Biosystems, up from $1.3 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.3 million in Q4 2025 to a low of $635000.0 in Q1 2022.
  • Historically, Current Leases has averaged $1.0 million across 4 years, with a median of $1.1 million in 2023.
  • Biggest five-year swings in Current Leases: surged 49.16% in 2024 and later rose 6.92% in 2025.
  • Year by year, Current Leases stood at $766000.0 in 2022, then surged by 47.78% to $1.1 million in 2023, then increased by 7.24% to $1.2 million in 2024, then increased by 6.92% to $1.3 million in 2025.
  • Business Quant data shows Current Leases for RPID at $1.3 million in Q4 2025, $1.3 million in Q3 2025, and $1.3 million in Q2 2025.